Suppr超能文献

一项针对注意力缺陷多动障碍(ADHD)儿童家长的基于正念减压(MBSR)计划的有效性:一项试点随机对照试验。

The effectiveness of a mindfulness-based stress reduction (MBSR) programme for parents of children with attention deficit hyperactivity disorder (ADHD): a pilot randomized controlled trial.

作者信息

Law Tsui Yuk, Bressington Daniel, Ruan Jiayin, Wong Wai Kit, Mak Yim Wah

机构信息

School of Nursing, The Hong Kong Polytechnic University, Hung Hom, Kowloon, 999077, Hong Kong, China.

School of Nursing & Health Sciences, Hong Kong Metropolitan University, Homantin, Kowloon, Hong Kong, China.

出版信息

BMC Psychol. 2025 Apr 24;13(1):429. doi: 10.1186/s40359-025-02747-4.

Abstract

BACKGROUND

Parents of children with attention deficit hyperactivity disorder (ADHD) often experience high levels of parental stress. This has exacerbated during the coronavirus disease 2019 (COVID-19) pandemic. The aim of this study was to examine the effectiveness of mindfulness-based stress reduction (MBSR) programme in the Chinese population, which is feasible among Chinese parents during the COVID-19 pandemic period in reducing the parental stress of parents compared with the usual care group.

METHODS

This study was designed as a pilot randomized controlled trial with single-blind repeated measures. Parents of children aged 3-12 years with a diagnosis of ADHD were recruited from the parent resource center (PRC) of a local nongovernmental organization between June and August 2022. The participants were randomly assigned to the MBSR intervention group (n = 18) or usual care group (n = 18).

RESULTS

With respect to the feasibility of the study, all 36 participants who were randomized fully completed the MBSR programme and assessments, resulting in a 100% attendance rate. 66% of the participants in the intervention group reported satisfaction with the intervention, which was helpful in reducing stress. They were willing to stay on this mindfulness-based programme in the future. The results of the repeated-measures ANOVA revealed a significant difference in self-perceived stress reduction between the groups (p < 0.001, ES = 0.192). The of within-group results revealed that the mean score of the intervention group decreased from 29.44 before the intervention to 25.50 (p < 0.001) immediately after intervention, and further decreased to 24.72 (p < 0.05) at one month after the intervention. By using the parental stress scale, the interaction effects also revealed significant differences between groups (p < 0.001, ES = 0.599). The stress level of the intervention group decreased from 74.50 before intervention, to 68.94 (p < 0.001) immediately after intervention, and further decreased to 67.50 (p < 0.05) at one month after intervention. These reports revealed statistically significant improvements in stress reduction and parental stress reduction in the intervention group.

CONCLUSION

The pilot study revealed that MBSR is feasible and acceptable for parents of children with ADHD in Chinese culture. The findings also suggested that the MBSR programme was effective in reducing parental stress and enhancing mental well-being. This study was registered in the National Library of Medicine, National Center for Biotechnology Information Clinical Trials Registry as Version 1, and the trial registration data are available as NCT06210113, 28/2/2024.

摘要

背景

注意力缺陷多动障碍(ADHD)患儿的父母经常承受高水平的育儿压力。在2019年冠状病毒病(COVID-19)大流行期间,这种压力进一步加剧。本研究的目的是检验基于正念减压(MBSR)计划在中国人群中的有效性,该计划在COVID-19大流行期间对中国父母来说是可行的,与常规护理组相比,可减轻父母的育儿压力。

方法

本研究设计为一项单盲重复测量的试点随机对照试验。2022年6月至8月期间,从当地一个非政府组织的家长资源中心招募了3至12岁被诊断为ADHD的患儿的父母。参与者被随机分配到MBSR干预组(n = 18)或常规护理组(n = 18)。

结果

关于该研究的可行性,所有36名随机分组的参与者都完全完成了MBSR计划和评估,出勤率达到100%。干预组中66%的参与者表示对干预满意,这有助于减轻压力。他们愿意在未来继续参与这个基于正念的计划。重复测量方差分析的结果显示,两组之间在自我感知的压力减轻方面存在显著差异(p < 0.001,效应量ES = 0.192)。组内结果显示,干预组的平均得分从干预前的29.44降至干预后立即的25.50(p < 0.001),并在干预后一个月进一步降至24.72(p < 0.05)。通过使用育儿压力量表,交互效应也显示出组间存在显著差异(p < 0.001,效应量ES = 0.599)。干预组的压力水平从干预前的74.50降至干预后立即的68.94(p < 0.001),并在干预后一个月进一步降至67.50(p < 0.05)。这些报告显示,干预组在减轻压力和育儿压力方面有统计学上的显著改善。

结论

该试点研究表明,MBSR在中国文化中对ADHD患儿的父母来说是可行且可接受的。研究结果还表明,MBSR计划在减轻父母压力和增强心理健康方面是有效的。本研究已在国立医学图书馆、国家生物技术信息中心临床试验注册库注册为版本1,试验注册数据可在NCT06210113查询,2024年2月28日。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1788/12020007/c9d26b5c52b0/40359_2025_2747_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验